ATYR Q2 2019 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$94,000

Gross Profit

$94,000100.0% margin

Operating Income

-$6M-6001.1% margin

Net Income

-$6M-6221.3% margin

EPS (Diluted)

$-1.80

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$509,000

Balance Sheet

Total Assets

$49M

Total Liabilities

$19M

Stockholders' Equity

$30M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94,000	$0	—
Gross Profit	$94,000	$0	—
Operating Income	-$6M	-$10M	+43.4%
Net Income	-$6M	-$10M	+43.8%